Isaglidole

This classification denotes an anti-diabetic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) B51UC955KQ. European Medicines Agency schedules Isaglidole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08301MIG. Isaglidole generally arises in the molecular formula C11H13FN4. The term ISAGLIDOLE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 4, no. 3 1990, list 30.) ISAGLIDOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule isaglidole under HS 29332990 and SITC 51573. As of Q4 2014, ISAGLIDOLE remains US FDA's Preferred Term for this commodity. Isaglidole bears US NLM identifiers UMLS ID C1881270 and NCI Concept Code C65966. SMILES: C1CN=C(N1)NN2CC3=C(C2)C(=CC=C3)F.